Explore 3 Stock Ideas & Industry Insights Download Free Report

Motus GI Holdings Inc

Company price
0.0002 USD 0.00(0%)
Last update at 2026-11-19T21:00:00Z
VOLUME
1
Market Cap
0.00M

Momentum Score

…

Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
-
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Motus GI Holdings Inc is a medical device company developing and commercializing endoscopy tools, principally a colon-cleansing system designed for use during colonoscopy procedures. Long-term growth may be supported by rising colorectal screening demand, broader adoption in hospitals and ambulatory surgery centers, and potential procedural benefits such as improved mucosal visualization and fewer repeat exams. The technology appears positioned to address a clear clinical need that could support market uptake if commercial execution and reimbursement progress.
Key risks include execution and commercialization challenges, reimbursement and regulatory uncertainty, competition from alternative bowel-prep and endoscopy technologies, and limited liquidity and financing flexibility as an OTCQB-listed company.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
0.33M
Revenue Per Share
0.06
Gross Profit TTM
-0.08M
Debt / Equity
0.92
ROE
-1069.02%
Net Debt
-2.49M
ROCE
-301.21%
Diluted EPS TTM
-5.92

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -12.87M -18.60M -19.03M -19.26M -23.09M
Net income -12.87M -18.09M -18.91M -19.60M -22.59M
Selling general administrative 6.58M 7.61M 9.27M 9.56M 9.50M
Selling and marketing expenses 1.61M 4.42M 3.08M 3.53M 4.90M
Gross profit -0.59M -0.20M -0.23M -0.40M -0.03M
Reconciled depreciation 0.68M 0.84M 0.70M 0.38M 0.22M
Ebit -11.91M -17.85M -17.92M -19.05M -23.44M
Ebitda -11.23M -17.30M -18.06M -18.79M -23.43M
Depreciation and amortization 0.68M 0.55M -0.14M 0.26M 0.00M
Non operating income net other - - - -0.00M -0.00M
Operating income -11.91M -17.85M -17.92M -19.05M -23.44M
Other operating expenses 12.23M 18.44M 18.32M 19.14M 23.54M
Interest expense 0.76M 1.25M 0.72M 0.46M 0.00M
Tax provision - - - - 0.00M
Interest income - - - - 0.27M
Net interest income -0.76M -1.25M -0.72M -0.46M 0.27M
Income tax expense - -0.51M -0.12M 0.34M -0.49M
Total revenue 0.32M 0.59M 0.39M 0.10M 0.11M
Total operating expenses 11.32M 17.65M 17.69M 18.65M 23.41M
Cost of revenue 0.91M 0.80M 0.62M 0.50M 0.14M
Total other income expense net -0.96M -0.75M -1.11M -0.21M 0.35M
Net income from continuing ops -12.87M -18.60M -19.03M -19.26M -23.09M
Net income applicable to common shares - - -25.18M -19.26M -23.09M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 7.22M 17.65M 26.09M 24.06M 32.26M
Other current assets 0.48M 0.78M 0.79M 0.45M 0.34M
Total liab 4.54M 14.67M 16.43M 12.77M 13.93M
Total stockholder equity 2.69M 2.98M 9.66M 11.29M 18.33M
Other current liab 0.23M 0.05M 2.59M 2.39M 3.27M
Common stock - - 0.01M 0.00M 0.00M
Capital stock 0.00M 0.00M 0.01M 0.00M 0.00M
Retained earnings -154.22M -141.35M -122.75M -103.72M -84.46M
Other liab - - 1.76M 1.62M 1.87M
Other assets - - 0.01M 0.00M 0.01M
Cash 4.96M 14.04M 22.56M 20.82M 20.53M
Total current liabilities 3.27M 4.80M 2.90M 10.61M 11.34M
Net debt -2.49M -2.61M -10.48M -12.05M -11.74M
Short term debt 1.20M 2.78M 0.31M 8.22M 8.07M
Short long term debt 1.03M 2.53M - 7.98M 7.75M
Short long term debt total 2.47M 11.44M 12.08M 8.76M 8.79M
Other stockholder equity 156.91M 144.33M 132.41M 115.01M 102.79M
Property plant equipment - - 2.12M 1.94M 2.08M
Total current assets 5.76M 15.37M 23.96M 22.11M 30.17M
Net tangible assets - - 9.66M 11.29M 18.33M
Short term investments - - - 0.00M 8.20M
Net receivables 0.08M 0.06M 0.11M 0.04M 0.08M
Long term debt 1.24M 8.48M 11.39M - -
Inventory 0.24M 0.49M 0.50M 0.81M 1.01M
Accounts payable 1.84M 1.97M 2.58M 0.00M 3.00M
Accumulated other comprehensive income - - - - -0.63M
Common stock total equity - - - 0.00M 0.00M
Retained earnings total equity - - - -103.72M -84.46M
Non currrent assets other 0.26M 0.52M 0.01M 0.01M 0.01M
Non current assets total 1.47M 2.28M 2.13M 1.96M 2.09M
Capital lease obligations 0.20M 0.42M 0.69M 0.79M 1.03M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -0.10M -0.22M -0.47M 8.12M 4.50M
Change to liabilities - - 0.30M -0.49M 0.39M
Total cashflows from investing activities - - -0.47M 8.12M -5.62M
Net borrowings -4.96M - 3.78M -0.03M 8.00M
Total cash from financing activities 2.41M 9.17M 16.64M 9.17M 28.02M
Change to operating activities - - -0.72M -0.55M -0.10M
Net income -12.87M -18.60M -19.03M -19.26M -23.09M
Change in cash -9.08M -8.52M 1.74M 0.29M 2.48M
Begin period cash flow 14.04M 22.56M 20.82M 20.53M 18.05M
End period cash flow 4.96M 14.04M 22.56M 20.82M 20.53M
Total cash from operating activities -11.39M -17.47M -14.42M -16.99M -19.91M
Issuance of capital stock 8.66M 10.25M 1.90M 9.99M 20.00M
Depreciation 0.68M 0.84M 0.70M 0.38M 0.22M
Other cashflows from investing activities - - - - -9.65M
Dividends paid 1.48M - - - -
Change to inventory 0.00M -1.30M -0.27M -0.62M -0.97M
Change to account receivables -0.02M 0.05M -0.07M 0.03M -0.06M
Sale purchase of stock -0.01M -0.01M - 0.06M 20.00M
Other cashflows from financing activities 1.49M -0.37M 22.96M -0.82M 8.02M
Change to netincome - - 4.84M 3.49M 3.31M
Capital expenditures 0.10M 0.22M 0.47M 0.09M 0.47M
Change receivables - - - 0.05M -0.06M
Cash flows other operating - - - 0.21M 0.28M
Cash and cash equivalents changes - - - 0.29M 2.48M
Change in working capital -0.41M -2.18M -0.77M -1.63M -0.51M
Stock based compensation 0.47M 2.04M 3.71M 3.07M 3.21M
Other non cash items 0.26M 0.43M 0.29M 0.03M 0.14M
Free cash flow -11.50M -17.69M -14.89M -17.08M -20.38M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MOTS
Motus GI Holdings Inc
-
-%
0.00 - - 0.00 - 4.58 0.03
ABT
Abbott Laboratories
-0.20
0.19%
103.00 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC
-0.59
0.59%
100.02 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation
-
-%
310.00 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG
-
-%
48.34 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Motus GI Holdings Inc

Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.

1301 East Broward Boulevard, Fort Lauderdale, FL, United States, 33301

954 541 8000

15

Name Title Year Born
Mr. Timothy P. Moran CEO & Director 1972
Mr. Mark Pomeranz Pres, COO & Director 1962
Mr. Andrew Lawrence Taylor M.B.A. Chief Financial Officer 1972
Mr. Scott C. Aldrich Jr. VP of Global Marketing & Strategy NA
Ms. Ravit Ram CFO & VP of Global Operations 1975
Mr. Elad Amor Chief Accounting Officer 1984
Jeff Varsalone President & Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…